GANGAPHARM

The stock has been placed in Graded Surveillance Measure (GSM) list GSM - 0.

Ganga Pharmaceuticals Ltd.

BSE: 539680

SME

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

12.50+0.0 (+0.00%)

8 Sep, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap

7.39

P/E (TTM)

72.81

P/B

0.89

P/S (TTM)

2.61

EV/EBITDA

215.39

CAPE (5Y)

ROE (TTM)

1.31

ROCE (TTM)

-0.19

ROA (TTM)

1.09

Avg 3Y ROE

1.06

Earnings 3Y CAGR

20.65

Sales 3Y CAGR

3.02

Sales 5Y CAGR

Debt/Equity

0.13

Consensus TP

Strong Buy %

Promoter Holding

Pledged %

Stock Analysis

Fundamental analysis overview of Ganga Pharmaceuticals Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Not enough talking points with positive stance

Negative

Expensive and at a premium to industry median P/E

PE TTM of 72.81 indicates that the stock is expensive on a standalone basis and is at a 131.29% premium to industry median P/E

What is P/E Ratio?

Median: 31.48

Value 72.81

-0.8734.68

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Not enough talking points with neutral stance

Financial Snapshot

See detailed analysis

Multi-year trends for Ganga Pharmaceuticals Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Ganga Pharmaceuticals Ltd. Shareholding Pattern

Quarterly breakdown of Ganga Pharmaceuticals Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Sep 2023	Dec 2023	Mar 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026
Total Promoter	66.71	66.71	66.71	66.71	66.71	66.71	66.71	66.71	66.71	66.71	66.71	66.71	66.71	66.71	66.71	66.71	66.71	56.02	56.02	56.02	56.02	50.91	50.91	50.91
Indian Promoter	66.71	66.71	66.71	66.71	66.71	66.71	66.71	66.71	66.71	66.71	66.71	66.71	66.71	66.71	66.71	66.71	66.71	56.02	56.02	56.02	56.02	50.91	50.91	50.91
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	33.29	33.29	33.29	33.29	33.29	33.29	33.29	33.29	33.29	33.29	33.29	33.29	33.29	33.29	33.29	33.29	33.29	43.98	43.98	43.98	43.98	49.09	49.09	49.09
Bodies Corporate	-	-	4.73	4.73	0.59	0.65	0.59	-	-	-	-	-	-	-	0.79	0.79	0.98	8.42	8.25	8.25	8.25	13.09	13.09	13.09
Others (incl. Retail) No. of shareholders	33.29 344	33.29 344	28.56 342	28.56 340	32.70 343	32.64 343	32.70 343	33.29 346	33.29 345	33.29 345	33.29 345	33.29 345	33.29 347	33.29 347	32.50 344	32.50 345	32.31 348	35.56 351	35.73 353	35.73 355	35.73 358	36.00 356	36.00 355	36.00 354

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Ganga Pharmaceuticals Ltd. shares as reported to NSE and BSE.

Name	Date	Type	Price	Qty.	Value
Rajaramchoudhary	11 Apr 2025	buy	₹ 11.18	32.00 k	₹ 3.58 lac
Pankaj Keshav Torne	21 Feb 2025	sell	₹ 10.98	48.00 k	₹ 5.27 lac
Anju Agarwal	24 Aug 2023	sell	₹ 10.70	40.00 k	₹ 4.28 lac
Pankaj Keshav Torne	24 Aug 2023	buy	₹ 10.70	40.00 k	₹ 4.28 lac
Niranjan Kumar Goel	15 Feb 2022	buy	₹ 15.37	32.00 k	₹ 4.92 lac
Niranjan Kumar Goel	14 Feb 2022	buy	₹ 16.05	24.00 k	₹ 3.85 lac
Babalbhai Manilal Patel	28 Jan 2022	sell	₹ 11.01	24.00 k	₹ 2.64 lac
Babalbhai Manilal Patel	25 Jan 2022	sell	₹ 11.42	24.00 k	₹ 2.74 lac
Muneesh Kapoor	25 Jan 2022	buy	₹ 11.42	24.00 k	₹ 2.74 lac

No corporate action data available.

Company Profile

Overview of Ganga Pharmaceuticals Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Ganga Pharmaceuticals Limited is an India-based company. The Company is engaged in the production of ayurvedic medicine. Apart from manufacturing, the Company is also into marketing and distribution of ayurvedic medicines. It offers ayurvedic medicines for acidity, antidandruff, antioxidants, blood ...

Key personnel

Mr. Anagh Bharat Sharma

Chief Financial Officer

Ms. Priti Kothari Bhaiya

Compliance Officer, Company Secretary

Mr. Sanjay Vyankatesh KulkarniD

Non-Executive Chairman of the Board

Mr. Bharat Brijmohan SharmaD

Chief Executive Officer, Managing Director, Executive Director

Mrs. Srijna Bharat SharmaD

Whole Time Director

Mr. Aman Mukesh ChaudhariD

Additional Non-Executive Independent Director

Mr. Munna Baijnath ChaurasiaD

Additional Non-Executive Independent Director

Mr. Sachin Chandrakant ChavanD

Non-Executive Independent Director

View all

Incorporated on

11 Sep 1989

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

IPO date

22 Feb 2016

Free Float

11,47,950

Website

https://www.ayurvedganga.com/

Phone no.

+912506098333

Address

Gangatat, Dhanvantary Marg, Gopchar Pada, Virar (East), MUMBAI, 401305, India

Frequently Asked Questions

What is the current share price of Ganga Pharmaceuticals Ltd.?

The current share price of Ganga Pharmaceuticals Ltd. is ₹ 12.50 as of 8 Sep 2026.

What is the market capitalisation of Ganga Pharmaceuticals Ltd.?

The market capitalisation of Ganga Pharmaceuticals Ltd. stands at ₹ 7.39 Cr.

What is the PE ratio of Ganga Pharmaceuticals Ltd.?

The Price-to-Earnings (PE) ratio of Ganga Pharmaceuticals Ltd. is 72.81 as of the latest trailing twelve months data.

What is the ROE and ROCE of Ganga Pharmaceuticals Ltd.?

Ganga Pharmaceuticals Ltd. has a Return on Equity (ROE) of 1.31% and a Return on Capital Employed (ROCE) of -0.19% as per the latest financial reports.

What is the 52-week high and low of Ganga Pharmaceuticals Ltd.?

The 52-week high of Ganga Pharmaceuticals Ltd. is - and the 52-week low is -.

What is the dividend yield of Ganga Pharmaceuticals Ltd.?

The dividend yield of Ganga Pharmaceuticals Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Ganga Pharmaceuticals Ltd.?

Foreign Institutional Investors (FII) hold -, Domestic Institutional Investors (DII) hold - of Ganga Pharmaceuticals Ltd. shares.

What sector does Ganga Pharmaceuticals Ltd. belong to?

Ganga Pharmaceuticals Ltd. operates in the Healthcare sector.

What is the beta of Ganga Pharmaceuticals Ltd.?

The beta of Ganga Pharmaceuticals Ltd. is 0.38, indicating its price volatility relative to the broader market.

What is the RSI of Ganga Pharmaceuticals Ltd.?

The 14-day Relative Strength Index (RSI) of Ganga Pharmaceuticals Ltd. is 46.70, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Ganga Pharmaceuticals Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Ganga Pharmaceuticals Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Company Profile

Frequently Asked Questions

Stock Analysis

Company Profile